Press Releases

New FDA Approval Extends Label to Including the i:X's Detection of Bacteria and Digital Wound Measurement TORONTO, Dec. 5, 2019 /PRNewswire/ - MolecuLight Inc., the world's leader in handheld fluorescence imaging for real-time visualization of fluorescence in wounds, has received FDA 510(k) clearance for its i:

WASHINGTON, Dec. 5, 2019 /PRNewswire/ -- The Global Alliance for Cannabis Commerce (GACC), a trade organization representing a major cross-section of the global cannabis industry, today announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. It is expected by the end of 2020 this program will be a

ST. LOUIS and TAMPA, Fla., Dec. 5, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") and WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") today announced that the Illinois Department of Insurance, the New Jersey Department of Banking and Insurance and the New Jersey Division of Medical Assistance and Health Se

Growth capital to support expansion of Suvoda's clinical trial software and services CONSHOHOCKEN, Pa., Dec. 5, 2019 /PRNewswire/ -- Suvoda LLC, a SaaS provider of clinical trial software, announced it secured a $40 million minority equity investment from Philadelphia-based private equity firm,

OVERLAND PARK, Kan., Dec. 5, 2019 /PRNewswire/ -- Intouch Group, a full-service agency network serving the pharmaceutical industry, has been named a Best Place to Work by Medical Marketing & Media (MM&M) magazine. The accolade, based on employee input and a panel of MM&M judges, recognizes healthcare marketing organizations that "stand out

TOKYO, Dec. 5, 2019 /PRNewswire/ -- bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President: Hitoshi Nakagama, Chuo-ku, Tokyo, "NCC") have signed a collaborative research agreement on

FREMONT, Calif., Dec. 4, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced the pricing of an underwritten public offering of 20,000,000 shares of its co

SAN FRANCISCO, Dec. 4, 2019 /PRNewswire/ -- Hagens Berman urges Merit Medical Systems, Inc. (NASDAQ: MMSI) investors who have suffered losses in excess of $50,000 to

ORLANDO, Fla., Dec. 4, 2019 /PRNewswire/ -- Servier Group and Servier Pharmaceuticals, the U.S. subsidiary of the global French pharmaceutical company, today announced that data from multiple studies will be presented at the 61st Annual Meeting of the American Society of Hematology (ASH) in Orlando, from

SAN CARLOS, Calif., Dec. 4, 2019 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical company developing therapeutic antibodies for the treatment of cancer and autoimmune diseases, today announced the creation of its Scientific Advisory Board (SAB) to support RubrYc's management regarding R&D priorities, therapeutic targ